The seroepidemiology and transmission dynamics of varicella in Australia

Epidemiology and Infection

Volumn 131, Issue 3, 2003, Pages 1085-1089

  Gidding, H F ^a,c   MacIntyre, C R ^a   Burgess, M A ^a   Gilbert, G L ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c Natl Ctr for Immunization Res   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BLOOD SAMPLING; CHICKENPOX; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GEOGRAPHY; GROUPS BY AGE; HUMAN; INFECTION SENSITIVITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; SEROEPIDEMIOLOGY; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; AUSTRALIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOENZYME TECHNIQUES; INFANT; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS;

EID: 1042269496     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803001134     Document Type: Article

References (25)

1. Chant KG, Sullivan EA, Burgess MA, et al. Varicellazoster virus infection in Australia. Aust NZ J Public Health 1998; 22: 413-418.
2. Ferson MJ, Bell SM, Robertson PW. Determination and importance of varicella immune status of nursing staff in a children's hospital. J Hosp Infect 1990; 15: 347-351.
3. McIntyre P, Gidding HF, Gilmour R, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999-2000. Comm Dis Intell 2002; (Suppl) May 2002.
4. Australian Institute of Health and Welfare National Hospital Mortality database.
5. Forrest J, Mego S, Burgess M. Congenital and neonatal varicella in Australia. J Paediatr Child Health 2000; 36: 108-113.
6. Jorm LR, Capon AG. Communicable disease outbreaks in long day care centres in western Sydney: occurrence and risk factors. J Paediatr Child Health 1994; 30: 151-154.
7. Grenfell BT, Anderson RM. The estimation of age-related rates of infection from case notifications and serological data. J Hyg (Lond) 1985; 95: 419-436.
8. Nokes DJ, Anderson RM, Anderson MJ. Rubella epidemiology in South East England. J Hyg (Lond) 1986; 96: 291-304.
9. Anderson RM, May RM. Infectious diseases of humans. Oxford: Oxford University Press, 1999.
10. Kanra G, Tezcan S, Badur S, Turkish National Study Team. Varicella seroprevalence in a random sample of the Turkish population. Vaccine 2002; 20: 1425-1428.
11. Aebi C, Fischer K, Gorgievski M, Matter L, Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine 2001; 19: 3097-3103.
12. Fairley CK, Miller E. Varicella-zoster virus epidemiology a changing scene? J Infect Dis 1996; 174 (Suppl 3): S314-S319.
13. Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001; 20: 121-124.
14. Salleras L, Dominguez A, Vidal J, Plans P, Salleras M, Taberner JL. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine 2000; 19: 183-188.
15. Gabutti G, Penna C, Rossi M, et al. The seroepidemiology of varicella in Italy. Epidemiol Infect 2001; 126: 433-440.
16. Kilgore PE, Kruszon-Moran D, Seward JF, et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 2003; 70: S111-S118.
17. Karunajeewa H, Siebert D, Hammond R, Garland S, Kelly H. Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management. Aust NZ J Obstet Gynaecol 2001; 41: 23-28.
18. O'Grady KA, Merianos A, Patel M, Gilbert L. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate. Trop Med Int Health 2000; 5: 732-736.
19. Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 1994; 140: 81-104.
20. Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001; 127: 305-314.
21. Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia. Vaccine 1999; 18: 407-415.
22. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000; 125: 651-669.
23. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20: 2500-2507.
24. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case control study. Lancet 2002; 360: 678-682.
25. Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002; 20: 3130-3136.